Compounds > triiodothyronine

Page last updated: 2024-08-17

triiodothyronine and carbidopa

triiodothyronine has been researched along with carbidopa in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (37.50)	18.7374
1990's	1 (12.50)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Aramendi, T; Argente, J; Cabranes, JA; Calle-Pascual, AL; Catalan, MJ; Charro, AL; Garcia-Mauriño, ML; Martin, P; Uria, J; Yuste, E	1
Caraceni, T; Cocchi, D; Giovannini, P; Martinez-Campos, A; Müller, EE; Novelli, A	1
Berger, JR; Kelley, RE	1
James, WP; Jung, RT; Liddell, F; Shetty, PS	1

Reviews

1 review(s) available for triiodothyronine and carbidopa

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

7 other study(ies) available for triiodothyronine and carbidopa

Article	Year
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Association of a thyrotropin-secreting pituitary adenoma and a thyroid follicular carcinoma. Journal of endocrinological investigation, 1991, Volume: 14, Issue:6 Topics: Adenocarcinoma; Adenoma; Brain; Carbidopa; Drug Therapy, Combination; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hydrocortisone; Insulin; Levodopa; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Radioimmunoassay; Thyroid Neoplasms; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Tomography, X-Ray Computed; Triiodothyronine	1991
Thyrotrophin and prolactin responses to thyrotrophin-releasing hormone in patients with Parkinson's disease. Acta endocrinologica, 1982, Volume: 99, Issue:3 Topics: Adult; Aged; Antiparkinson Agents; Benserazide; Carbidopa; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine	1982
Thyroid function in Parkinson disease. Neurology, 1981, Volume: 31, Issue:1 Topics: Aged; Carbidopa; Humans; Hypothyroidism; Levodopa; Middle Aged; Parkinson Disease; Prospective Studies; Thyroid Diseases; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyronine	1981
The effect of levodopa with carbidopa (Sinemet R) on the metabolic response to semistarvation. International journal of obesity, 1980, Volume: 4, Issue:3 Topics: Adaptation, Physiological; Aromatic Amino Acid Decarboxylase Inhibitors; Basal Metabolism; Carbidopa; Diet, Reducing; Drug Combinations; Energy Intake; Female; Humans; Levodopa; Middle Aged; Obesity; Triiodothyronine	1980